<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Hung KC</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Type 2 diabetes mellitus (T2DM) is a major global health challenge, with diabetic kidney disease (DKD) representing one of its most serious complications. Although zinc deficiency is common in diabetes, large-scale clinical evidence on its role as a predictor of new-onset DKD is limited.&lt;h4>Methods&lt;/h4>We conducted a retrospective cohort study using the TriNetX Analytics Network Platform to analyze patients aged ≥18 years who underwent zinc testing (2010-2023). Patients were classified into zinc deficiency (serum zinc &lt;70 μg/dL) and control groups (70-120 μg/dL). After 1:1 propensity score matching, we analyzed the risk of new-onset DKD at two-year follow-up. The secondary outcomes included the risks of all-cause mortality, acute kidney injury (AKI), chronic kidney disea</pubmed_abstract><journal>Frontiers in nutrition</journal><pagination>1653151</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12504847</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Zinc deficiency predicts new-onset diabetic kidney disease in type 2 diabetes: a retrospective cohort study.</pubmed_title><pmcid>PMC12504847</pmcid><pubmed_authors>Lin YT</pubmed_authors><pubmed_authors>Lai YC</pubmed_authors><pubmed_authors>Lin CM</pubmed_authors><pubmed_authors>Hung KC</pubmed_authors><pubmed_authors>Tan PH</pubmed_authors><pubmed_authors>Yu TS</pubmed_authors><pubmed_authors>Chen IW</pubmed_authors><pubmed_authors>Hsu CW</pubmed_authors><pubmed_authors>Wang LK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Zinc deficiency predicts new-onset diabetic kidney disease in type 2 diabetes: a retrospective cohort study.</name><description>&lt;h4>Background&lt;/h4>Type 2 diabetes mellitus (T2DM) is a major global health challenge, with diabetic kidney disease (DKD) representing one of its most serious complications. Although zinc deficiency is common in diabetes, large-scale clinical evidence on its role as a predictor of new-onset DKD is limited.&lt;h4>Methods&lt;/h4>We conducted a retrospective cohort study using the TriNetX Analytics Network Platform to analyze patients aged ≥18 years who underwent zinc testing (2010-2023). Patients were classified into zinc deficiency (serum zinc &lt;70 μg/dL) and control groups (70-120 μg/dL). After 1:1 propensity score matching, we analyzed the risk of new-onset DKD at two-year follow-up. The secondary outcomes included the risks of all-cause mortality, acute kidney injury (AKI), chronic kidney disea</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-04T09:01:41.457Z</modification><creation>2026-06-01T03:06:41.396Z</creation></dates><accession>S-EPMC12504847</accession><cross_references><pubmed>41070026</pubmed><doi>10.3389/fnut.2025.1653151</doi></cross_references></HashMap>